The client has been receiving spironolactone (Aldactone) 50 mg/day for heart failure. The nurse should closely monitor the client for which condition?
Hypokalemia
Hyperkalemia
Hypoglycemia
Hypermagnesemia
The Correct Answer is B
Spironolactone is a steroid-based aldosterone antagonist that competitively inhibits mineralocorticoid receptors in the distal renal tubules. This potassium-sparing diuretic prevents the reabsorption of sodium while inhibiting the active secretion of potassium and hydrogen ions. It effectively manages heart failure by mitigating the deleterious effects of hyperaldosteronism and cardiac remodeling. Side effects include gynecomastia, menstrual irregularities, and life-threatening electrolyte disturbances.
Rationale for correct answer
B. By antagonizing the mineralocorticoid receptor, spironolactone prevents the renal collecting duct from excreting potassium in exchange for sodium. This pharmacological mechanism leads directly to the retention of potassium, resulting in hyperkalemia (serum potassium > 5.0 mEq/L). This condition is the most dangerous metabolic complication of therapy. The nurse must monitor for cardiac dysrhythmias or peaked T-waves.
Rationale for incorrect answers
A. Loop and thiazide diuretics cause the loss of potassium, but spironolactone belongs to the potassium-sparing class which prevents such depletion. Consequently, hypokalemia is not a characteristic adverse effect of this specific medication. Patients are actually instructed to avoid high-potassium diets. This prevents the risk of myocardial instability associated with low potassium.
C. Spironolactone does not interfere with pancreatic insulin secretion or hepatic gluconeogenesis pathways to cause a drop in blood sugar. While some diuretics impact glucose, hypoglycemia is not a documented or expected side effect of aldosterone antagonists. The drug primarily influences electrolyte homeostasis rather than carbohydrate metabolism. Diabetic monitoring focuses more on potassium-induced insulin shifts.
D. Although diuretics can occasionally influence secondary mineral levels, spironolactone is not a primary cause of significant hypermagnesemia. Excessive magnesium levels ( > 2.2 mEq/L) are typically associated with renal failure or antacid overuse. The clinical priority for this drug remains the potassium balance. Magnesium shifts are rarely the primary clinical concern during standard dosing.
Test-taking strategy
- Identify the drug class: Categorize spironolactone as a potassium-sparing diuretic.
- Recall the physiological trade-off:
- Normal aldosterone causes the body to keep sodium and lose potassium.
- An aldosterone antagonist does the opposite: it loses sodium and keeps potassium.
- Evaluate the suffix/prefix: Recognize the "one" suffix often denotes a steroid-related structure, which in this case competes with the steroid hormone aldosterone.
- Match the mechanism to the risk: If the body is "sparing" or keeping potassium, the primary risk must be an excess of that ion.
- Differentiate from other diuretics: Contrast this with "potassium-wasting" diuretics like furosemide (loop) or hydrochlorothiazide (thiazide).
- Select the high-acuity answer: Hyperkalemia (Option 2) is the most common and life-threatening risk associated with this specific drug's mechanism of action.
Take home points
- Spironolactone is used in heart failure to block the effects of aldosterone, which helps prevent myocardial fibrosis and sodium retention.
- The most critical nursing priority is monitoring for hyperkalemia, especially in patients with impaired renal function or those taking ACE inhibitors.
- Patients should be educated to avoid salt substitutes containing potassium chloride, as these can cause lethal increases in serum potassium.
- Endocrine side effects such as gynecomastia or breast tenderness may occur because spironolactone can also bind to androgen and progesterone receptors.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Loop diuretics are potent inhibitors of the Na+/K+/2Cl- symporter in the thick ascending limb of the loop of Henle. These agents manage fluid overload but can disrupt the endolymph potential in the inner ear. Concomitant use with aminoglycosides increases the risk of irreversible sensorineural hearing loss and vestibular dysfunction. These drugs are contraindicated in states of anuria or severe sulfonamide hypersensitivity.
Rationale for correct answer
B. Both loop diuretics and aminoglycosides possess inherent ototoxic properties that affect the cochlear and vestibular systems. When administered concurrently, they exert a synergistic toxic effect on the hair cells within the inner ear. This interaction can lead to permanent deafness or significant tinnitus. The nurse must perform baseline and periodic auditory assessments to detect early damage.
Rationale for incorrect answers
A. While aminoglycosides are well-documented to cause renal tubular necrosis, furosemide is not primarily classified as a potent nephrotoxic agent. Although excessive diuresis can lead to prerenal azotemia, the specific synergy for renal damage is less characteristic than the synergy for auditory damage. The combined risk of ototoxicity is the most specific and profound interaction between these drug classes.
C. Pulmonary fibrosis is a chronic progressive lung disease often associated with medications like amiodarone or bleomycin. Neither aminoglycoside antibiotics nor loop diuretics are scientifically linked to the development of alveolar scarring or fibrotic changes. Monitoring for respiratory distress in this patient is related to their pneumonia and fluid overload, not a drug-induced fibrotic reaction.
D. Hepatotoxicity involves drug-induced injury to the hepatic parenchyma, commonly seen with medications like acetaminophen or isoniazid. Aminoglycosides and loop diuretics are primarily cleared and processed via renal mechanisms rather than hepatic pathways. There is no significant pharmacological evidence suggesting that this specific combination leads to liver failure. Serum transaminase monitoring is not the priority for this specific drug-drug interaction.
Test-taking strategy
- Identify shared adverse effects: When two different drug classes are administered together, look for a common "toxic" thread in their side effect profiles.
- Recall specific toxicities:
- Aminoglycosides (e.g., gentamicin) are known for ototoxicity and nephrotoxicity.
- Loop diuretics (e.g., furosemide) are known for ototoxicity, especially when given in high doses or rapidly.
- Apply the principle of synergy: Since both drugs can damage the same physiological system (the auditory nerve/inner ear), the combined risk is significantly amplified.
- Eliminate based on primary organ systems:
- Rule out option 4 (liver) and option 3 (lungs) as these drugs do not target those tissues.
- While nephrotoxicity (option 1) is a risk for aminoglycosides, the "interaction" or synergy with loop diuretics is most classically and dangerously associated with hearing loss.
Take home points
- The combination of loop diuretics and aminoglycosides significantly elevates the risk of permanent sensorineural ototoxicity.
- Nurses should monitor patients for symptoms such as tinnitus, vertigo, or perceived hearing loss during therapy.
- Rapid intravenous infusion of furosemide (exceeding 4 mg/min) should be avoided to minimize the risk of transient or permanent deafness.
- Baseline and serial audiograms may be indicated for patients receiving prolonged courses of these interacting medications.
Correct Answer is ["A","B","C"]
Explanation
Diuretics modulate hydro-electrolytic homeostasis by altering tubular reabsorption of solutes in the nephron. These agents treat heart failure and portal hypertension, but their metabolic profile often induces hyperglycemia and significant fluid shifts. In patients with hepatic or renal impairment, altered pharmacokinetics can lead to rapid circulatory collapse or encephalopathy.
Rationale for correct answers
A. Thiazide and loop diuretics interfere with pancreatic insulin release and peripheral glucose utilization. This pharmacological interference leads to hyperglycemia, requiring frequent monitoring in diabetic populations. Elevated blood glucose levels can destabilize metabolic control. Dosage adjustments of hypoglycemic agents may be necessary.
B. Cirrhotic patients often exhibit baseline peripheral vasodilation and decreased effective volume. Diuretic-induced fluid removal can precipitously lower intravascular pressure, resulting in severe orthostatic hypotension. Rapid shifts in fluid compartments increase the risk of syncope. This can further compromise already fragile hepatic perfusion.
C. Impaired kidneys cannot effectively regulate the excretion and retention of ions during forced diuresis. This leads to profound electrolyte imbalances, specifically hypokalemia, hyponatremia, and hypermagnesemia. Careful monitoring of serum chemistries is required to prevent life-threatening cardiac dysrhythmias. Renal clearance directly dictates the severity of these disturbances.
Rationale for incorrect answers
D. Diuretics are associated with metabolic "highs," including elevated glucose, rather than hypoglycemia. The decrease in insulin sensitivity and potassium-related inhibition of insulin secretion prevents low sugar states. Using the term hypoglycemia is scientifically inaccurate for this medication class. Patients are at higher risk for ketoacidosis than insulin shock.
E. Diuretics are specifically indicated to reduce, not cause, edema by promoting natriuresis. If edema develops during therapy, it is likely due to the underlying renal disease rather than a side effect of the drug. Claiming diuretics cause secondary edema contradicts their primary physiological function. Successful therapy results in a net loss of interstitial fluid.
Test-taking strategy
- Identify the drug-condition interaction: The question focuses on how diuretics affect specific vulnerable populations like those with renal, hepatic, or diabetic issues.
- Recall metabolic effects: Use the "Hyper" rule for diuretics (Hyperglycemia, Hyperlipidemia, Hyperuricemia).
- This allows for the selection of option 1 (hyperglycemia) and the elimination of option 4 (hypoglycemia).
- Assess hemodynamic risks:
- Cirrhotic patients have low oncotic pressure. Removing fluid from their blood volume quickly leads to hypovolemia.
- This makes orthostatic hypotension (option 2) a correct and logical safety concern.
- Consider organ function:
- Renal disease means the kidneys cannot balance ions well.
- Diuretics force ion movement.
- Therefore, electrolyte imbalances (option 3) are inevitable and must be monitored.
- Evaluate therapeutic goals:
- Diuretics are the treatment for edema.
- Therefore, saying they "cause edema" (option 5) is a direct contradiction of their medical purpose.
Take home points
- Diuretics are known to increase blood glucose levels, necessitating close surveillance of diabetic patients for hyperglycemia.
- In cirrhosis, diuretics must be titrated slowly to prevent rapid volume depletion and subsequent orthostatic hypotension or hepatic coma.
- Renal impairment increases the risk of severe electrolyte disturbances because the kidneys cannot compensate for drug-induced ion losses.
- Thiazides and loop diuretics should be avoided or used with extreme caution if the glomerular filtration rate is significantly diminished.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.